Brief: Ocugen, Inc. Announces Removal Of Clinical Hold On Investigational New Drug Application For Ocu200 Phase 1 Clinical Trial

Ocugen

09/10/2024 12:05

Ocugen Inc  OCGN.O :
    * OCUGEN, INC. ANNOUNCES REMOVAL OF CLINICAL HOLD ON
INVESTIGATIONAL NEW DRUG APPLICATION FOR OCU200 PHASE 1 CLINICAL
TRIAL
    * OCUGEN INC - TO PURSUE ADDITIONAL INDICATIONS FOR OCU200

Source text for Eikon:  ID:nGNX1JMp5J 
Further company coverage:  OCGN.O